These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 29889239

  • 1. Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.
    Chu CS, Phyo AP, Lwin KM, Win HH, San T, Aung AA, Raksapraidee R, Carrara VI, Bancone G, Watson J, Moore KA, Wiladphaingern J, Proux S, Sriprawat K, Winterberg M, Cheah PY, Chue AL, Tarning J, Imwong M, Nosten F, White NJ.
    Clin Infect Dis; 2018 Oct 30; 67(10):1543-1549. PubMed ID: 29889239
    [Abstract] [Full Text] [Related]

  • 2. Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
    Chu CS, Phyo AP, Turner C, Win HH, Poe NP, Yotyingaphiram W, Thinraow S, Wilairisak P, Raksapraidee R, Carrara VI, Paw MK, Wiladphaingern J, Proux S, Bancone G, Sriprawat K, Lee SJ, Jeeyapant A, Watson J, Tarning J, Imwong M, Nosten F, White NJ.
    Clin Infect Dis; 2019 Apr 08; 68(8):1311-1319. PubMed ID: 30952158
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand.
    Wilairatana P, Silachamroon U, Krudsood S, Singhasivanon P, Treeprasertsuk S, Bussaratid V, Phumratanaprapin W, Srivilirit S, Looareesuwan S.
    Am J Trop Med Hyg; 1999 Dec 08; 61(6):973-7. PubMed ID: 10674681
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.
    Yuan L, Wang Y, Parker DM, Gupta B, Yang Z, Liu H, Fan Q, Cao Y, Xiao Y, Lee MC, Zhou G, Yan G, Baird JK, Cui L.
    Antimicrob Agents Chemother; 2015 Feb 08; 59(2):1230-5. PubMed ID: 25512415
    [Abstract] [Full Text] [Related]

  • 5. The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.
    Commons RJ, Simpson JA, Thriemer K, Humphreys GS, Abreha T, Alemu SG, Añez A, Anstey NM, Awab GR, Baird JK, Barber BE, Borghini-Fuhrer I, Chu CS, D'Alessandro U, Dahal P, Daher A, de Vries PJ, Erhart A, Gomes MSM, Gonzalez-Ceron L, Grigg MJ, Heidari A, Hwang J, Kager PA, Ketema T, Khan WA, Lacerda MVG, Leslie T, Ley B, Lidia K, Monteiro WM, Nosten F, Pereira DB, Phan GT, Phyo AP, Rowland M, Saravu K, Sibley CH, Siqueira AM, Stepniewska K, Sutanto I, Taylor WRJ, Thwaites G, Tran BQ, Tran HT, Valecha N, Vieira JLF, Wangchuk S, William T, Woodrow CJ, Zuluaga-Idarraga L, Guerin PJ, White NJ, Price RN.
    Lancet Infect Dis; 2018 Sep 08; 18(9):1025-1034. PubMed ID: 30033231
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
    Yeshiwondim AK, Tekle AH, Dengela DO, Yohannes AM, Teklehaimanot A.
    Acta Trop; 2010 Feb 08; 113(2):105-13. PubMed ID: 19835832
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of an Unsupervised Primaquine Regimen for Preventing Plasmodium vivax Malaria Relapses in Northeast Myanmar: A Single-Arm Nonrandomized Observational Study.
    Malla P, Wang Z, Brashear A, Yang Z, Lo E, Baird K, Wang C, Cui L.
    J Infect Dis; 2024 May 15; 229(5):1557-1564. PubMed ID: 38041857
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.
    Hamedi Y, Safa O, Zare S, Tan-ariya P, Kojima S, Looareesuwan S.
    Southeast Asian J Trop Med Public Health; 2004 Sep 15; 35(3):570-4. PubMed ID: 15689068
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of Plasmodium vivax malaria recurrence in Brazil.
    Daher A, Silva JCAL, Stevens A, Marchesini P, Fontes CJ, Ter Kuile FO, Lalloo DG.
    Malar J; 2019 Jan 22; 18(1):18. PubMed ID: 30670020
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial.
    Grigg MJ, William T, Menon J, Barber BE, Wilkes CS, Rajahram GS, Edstein MD, Auburn S, Price RN, Yeo TW, Anstey NM.
    Clin Infect Dis; 2016 Jun 01; 62(11):1403-1411. PubMed ID: 27107287
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of Chloroquine and Primaquine for the Treatment of Uncomplicated Plasmodium vivax Malaria in Cruzeiro do Sul, Brazil.
    Negreiros S, Farias S, Viana GM, Okoth SA, Chenet SM, de Souza TM, Marchesini P, Udhayakumar V, Povoa MM, Santelli AC, de Oliveira AM.
    Am J Trop Med Hyg; 2016 Nov 02; 95(5):1061-1068. PubMed ID: 27549633
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study.
    Brito M, Rufatto R, Brito-Sousa JD, Murta F, Sampaio V, Balieiro P, Baía-Silva D, Castro V, Alves B, Alencar A, Duparc S, Grewal Daumerie P, Borghini-Fuhrer I, Jambert E, Peterka C, Edilson Lima F, Carvalho Maia L, Lucena Cruz C, Maciele B, Vasconcelos M, Machado M, Augusto Figueira E, Alcirley Balieiro A, Batista Pereira D, Lacerda M.
    Lancet Infect Dis; 2024 Jun 02; 24(6):629-638. PubMed ID: 38452779
    [Abstract] [Full Text] [Related]

  • 18. A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia.
    Pasaribu AP, Chokejindachai W, Sirivichayakul C, Tanomsing N, Chavez I, Tjitra E, Pasaribu S, Imwong M, White NJ, Dondorp AM.
    J Infect Dis; 2013 Dec 01; 208(11):1906-13. PubMed ID: 23926329
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.